These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29346085)

  • 21. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay.
    Eshleman SH; Khaki L; Laeyendecker O; Piwowar-Manning E; Johnson-Lewis L; Husnik M; Koblin B; Coates T; Chesney M; Vallari A; Devare SG; Hackett J
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):121-4. PubMed ID: 19506484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.
    Salmona M; Delarue S; Delaugerre C; Simon F; Maylin S
    J Clin Microbiol; 2014 Jan; 52(1):103-7. PubMed ID: 24153130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of a new vesion of the human immunodeficiency virus antigen and antibody combination assay with improved sensitivity in HIV-1 p24 antigen detection].
    Sano T; Kondo M; Yoshimura Y; Tachikawa N; Sagara H; Itoda I; Yamanaka K; Sudo K; Kato S; Imai M
    Kansenshogaku Zasshi; 2013 Jul; 87(4):415-23. PubMed ID: 23984590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could HIV-1 RNA Testing be an Option as the Second Step in the HIV Diagnostic Algorithm?
    Masciotra S; Luo W; Rossetti R; Smith T; Ethridge S; Delaney KP; Wesolowski LG; Owen SM
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S26-S31. PubMed ID: 31977972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.
    Duong YT; Mavengere Y; Patel H; Moore C; Manjengwa J; Sibandze D; Rasberry C; Mlambo C; Li Z; Emel L; Bock N; Moore J; Nkambule R; Justman J; Reed J; Bicego G; Ellenberger DL; Nkengasong JN; Parekh BS
    J Clin Microbiol; 2014 Oct; 52(10):3743-8. PubMed ID: 25122853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens.
    Rodgers MA; Vallari AS; Yamaguchi J; Holzmayer V; Harris B; Toure-Kane C; Mboup S; Badreddine S; McArthur C; Ndembi N; Mbanya D; Kaptue L; Cloherty G
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):314-318. PubMed ID: 29232958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.
    Curtis KA; Rudolph DL; Pan Y; Delaney K; Anastos K; DeHovitz J; Kassaye SG; Hanson CV; French AL; Golub E; Adimora AA; Ofotokun I; Bolivar H; Kempf MC; Peters PJ; Switzer WM
    PLoS One; 2021; 16(7):e0242641. PubMed ID: 34197451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of fourth-generation rapid combined antigen and antibody diagnostic tests for the detection of acute HIV infection in a community centre for men who have sex with men, between 2016 and 2019.
    Saz J; Dalmau-Bueno A; Meulbroek M; Pujol F; Coll J; Herraiz-Tomey Á; Pérez F; Marazzi G; Taboada H; Culqui DR; Caylà JA;
    PLoS One; 2021; 16(7):e0255065. PubMed ID: 34314468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of human immunodeficiency virus-1/2 antigen/antibody immunochromatographic assay.
    Deguchi M; Yoshioka N; Kagita M; Kita M; Asari S; Honda T; Kobayashi E
    Clin Lab; 2012; 58(11-12):1193-201. PubMed ID: 23289189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data on the relationship of signal-to-cutoff ratio of two HIV antigen/antibody combination assays to subsequent confirmation of HIV-1 infection in a low-prevalence population.
    Hodgson CK; Krasowski MD; Ford BA
    Data Brief; 2020 Aug; 31():105707. PubMed ID: 32462068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays.
    Weber B; Thorstensson R; Tanprasert S; Schmitt U; Melchior W
    Vox Sang; 2003 Aug; 85(2):73-9. PubMed ID: 12925157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the vitros hiv combo 4th generation test for the identification of HIV infections.
    De Paschale M; Manco MT; Cianflone A; Belvisi L; Cagnin D; Cerulli T; Paganini A; Agrappi C; Mirri P; Clerici P
    J Clin Virol; 2018 Nov; 108():77-82. PubMed ID: 30266004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Testing Algorithm Performance in a Low-Prevalence Environment.
    Martin EG; Cornett J; Mohammed DY; Salaru G
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S35-S40. PubMed ID: 31977973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.